Auris Health is an ambitious robotics company based in Silicon Valley. Auris was acquired for up to $6.1B by Johnson & Johnson in 2019.

Auris Health's vision begins with its Monarch Platform, an FDA-approved device that uses the latest advancements in robotics, software, data science and endoscope innovation to enter the body non-invasively to root out lung cancer.
-
Industry
-
Milestones
- Lux investment: 2012
- Acquired by JNJ: 2019
-
Founders
- Fred Moll
LUX Partners